Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1991 Oct;81(10):1247–1249. doi: 10.2105/ajph.81.10.1247

Injection drug use, mortality, and the AIDS epidemic.

P A Selwyn
PMCID: PMC1405332  PMID: 1928519

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball J. C., Lange W. R., Myers C. P., Friedman S. R. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav. 1988 Sep;29(3):214–226. [PubMed] [Google Scholar]
  2. Bewley T. H., Ben-Arie O., James I. P. Morbidity and mortality from heroin dependence. 1. Survey of heroin addicts known to home office. Br Med J. 1968 Mar 23;1(5594):725–726. doi: 10.1136/bmj.1.5594.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brettle R. P. HIV and harm reduction for injection drug users. AIDS. 1991 Feb;5(2):125–136. doi: 10.1097/00002030-199102000-00001. [DOI] [PubMed] [Google Scholar]
  4. Buehler J. W., Devine O. J., Berkelman R. L., Chevarley F. M. Impact of the human immunodeficiency virus epidemic on mortality trends in young men, United States. Am J Public Health. 1990 Sep;80(9):1080–1086. doi: 10.2105/ajph.80.9.1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cherubin C. E. The medical sequelae of narcotic addiction. Ann Intern Med. 1967 Jul;67(1):23–33. doi: 10.7326/0003-4819-67-1-23. [DOI] [PubMed] [Google Scholar]
  6. Cooper J. R. Methadone treatment and acquired immunodeficiency syndrome. JAMA. 1989 Sep 22;262(12):1664–1668. [PubMed] [Google Scholar]
  7. Des Jarlais D. C., Friedman S. R. HIV and intravenous drug use. AIDS. 1988;2 (Suppl 1):S65–S69. doi: 10.1097/00002030-198800001-00010. [DOI] [PubMed] [Google Scholar]
  8. Des Jarlais D. C., Friedman S. R., Novick D. M., Sotheran J. L., Thomas P., Yancovitz S. R., Mildvan D., Weber J., Kreek M. J., Maslansky R. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989 Feb 17;261(7):1008–1012. doi: 10.1001/jama.261.7.1008. [DOI] [PubMed] [Google Scholar]
  9. Dole V. P. Methadone treatment and the acquired immunodeficiency syndrome epidemic. JAMA. 1989 Sep 22;262(12):1681–1682. [PubMed] [Google Scholar]
  10. Gail M. H., Rosenberg P. S., Goedert J. J. Therapy may explain recent deficits in AIDS incidence. J Acquir Immune Defic Syndr. 1990;3(4):296–306. [PubMed] [Google Scholar]
  11. Galli M., Lazzarin A., Saracco A., Balotta C., Castagna A., Negri C., Ridolfo A. L., Uberti-Foppa C., Corbellino M., Moroni M. Clinical and immunological aspects of HIV infection in drug addicts. Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 2):S166–S176. doi: 10.1016/0090-1229(89)90124-4. [DOI] [PubMed] [Google Scholar]
  12. Ghodse A. H., Sheehan M., Taylor C., Edwards G. Deaths of drug addicts in the United Kingdom 1967-81. Br Med J (Clin Res Ed) 1985 Feb 9;290(6466):425–428. doi: 10.1136/bmj.290.6466.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hahn R. A., Onorato I. M., Jones T. S., Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA. 1989 May 12;261(18):2677–2684. [PubMed] [Google Scholar]
  14. Hartnoll R. L. Current situation relating to drug abuse assessment in European countries. Bull Narc. 1986 Jan-Jun;38(1-2):65–80. [PubMed] [Google Scholar]
  15. Helpern M. Fatalities from narcotic addiction in New York City. Incidence, circumstances, and pathologic findings. Hum Pathol. 1972 Mar;3(1):13–21. doi: 10.1016/s0046-8177(72)80050-9. [DOI] [PubMed] [Google Scholar]
  16. Hubbard R. L., Marsden M. E., Cavanaugh E., Rachal J. V., Ginzburg H. M. Role of drug-abuse treatment in limiting the spread of AIDS. Rev Infect Dis. 1988 Mar-Apr;10(2):377–384. doi: 10.1093/clinids/10.2.377. [DOI] [PubMed] [Google Scholar]
  17. Joe G. W., Lehman W., Simpson D. D. Addict death rates during a four-year posttreatment follow-up. Am J Public Health. 1982 Jul;72(7):703–709. doi: 10.2105/ajph.72.7.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Joe G. W., Simpson D. D. Mortality rates among opioid addicts in a longitudinal study. Am J Public Health. 1987 Mar;77(3):347–348. doi: 10.2105/ajph.77.3.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Louria D. B., Hensle T., Rose J. The major medical complications of heroin addiction. Ann Intern Med. 1967 Jul;67(1):1–22. doi: 10.7326/0003-4819-67-1-1. [DOI] [PubMed] [Google Scholar]
  20. Monfardini S., Vaccher E., Lazzarin A., Rezza G., Alessi E., Baroni C., Bernasconi C., Carbone A., Luzi G., Mandelli F. Characterization of AIDS-associated tumors in Italy: report of 435 cases of an IVDA-based series. Cancer Detect Prev. 1990;14(3):391–393. [PubMed] [Google Scholar]
  21. Monfardini S., Vaccher E., Pizzocaro G., Stellini R., Sinicco A., Sabbatani S., Marangolo M., Zagni R., Clerici M., Foà R. Unusual malignant tumours in 49 patients with HIV infection. AIDS. 1989 Jul;3(7):449–452. doi: 10.1097/00002030-198907000-00008. [DOI] [PubMed] [Google Scholar]
  22. Page J. B., Lai S. H., Chitwood D. D., Klimas N. G., Smith P. C., Fletcher M. A. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet. 1990 Jun 16;335(8703):1439–1441. doi: 10.1016/0140-6736(90)91456-k. [DOI] [PubMed] [Google Scholar]
  23. Perucci C. A., Davoli M., Rapiti E., Abeni D. D., Forastiere F. Mortality of intravenous drug users in Rome: a cohort study. Am J Public Health. 1991 Oct;81(10):1307–1310. doi: 10.2105/ajph.81.10.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rezza G., Titti F., Rossi G. B., Verani P., Menniti-Ippolito F., Oliva C. Sex as a risk factor for HTLV-I spread among intravenous drug abusers. Lancet. 1988 Mar 26;1(8587):713–713. doi: 10.1016/s0140-6736(88)91521-8. [DOI] [PubMed] [Google Scholar]
  25. Sato P. A., Chin J., Mann J. M. Review of AIDS and HIV infection: global epidemiology and statistics. AIDS. 1989;3 (Suppl 1):S301–S307. doi: 10.1097/00002030-198901001-00043. [DOI] [PubMed] [Google Scholar]
  26. Selwyn P. A., Feingold A. R., Hartel D., Schoenbaum E. E., Alderman M. H., Klein R. S., Friedland G. H. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS. 1988 Aug;2(4):267–272. doi: 10.1097/00002030-198808000-00005. [DOI] [PubMed] [Google Scholar]
  27. Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989 Mar 2;320(9):545–550. doi: 10.1056/NEJM198903023200901. [DOI] [PubMed] [Google Scholar]
  28. Selwyn P. A., Hartel D., Wasserman W., Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health. 1989 Oct;79(10):1358–1362. doi: 10.2105/ajph.79.10.1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Smith P. F., Mikl J., Hyde S., Morse D. L. The AIDS epidemic in New York State. Am J Public Health. 1991 May;81 (Suppl):54–60. doi: 10.2105/ajph.81.suppl.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stoneburner R. L., Des Jarlais D. C., Benezra D., Gorelkin L., Sotheran J. L., Friedman S. R., Schultz S., Marmor M., Mildvan D., Maslansky R. A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science. 1988 Nov 11;242(4880):916–919. doi: 10.1126/science.3187532. [DOI] [PubMed] [Google Scholar]
  31. Vaillant G. E. Twelve-year follow-up of New York narcotic addicts. II. The natural history of a chronic disease. N Engl J Med. 1966 Dec 8;275(23):1282–1288. doi: 10.1056/NEJM196612082752305. [DOI] [PubMed] [Google Scholar]
  32. Weber R., Ledergerber B., Opravil M., Siegenthaler W., Lüthy R. Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. BMJ. 1990 Dec 15;301(6765):1362–1365. doi: 10.1136/bmj.301.6765.1362. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES